October 17, 2025

FDA Awards Nine CNPV Vouchers to Speed Reviews

Pilot aims to expedite access to high‑impact therapies by streamlining FDA review and strengthening sponsor–agency collaboration.

Conexiant

October 16, 2025

Comprehensive Review Identifies Key Neonatal Death Risks

Review grades evidence on neonatal mortality across 64 reviews; methods and gaps outlined.

Conexiant

October 16, 2025

New Criteria, New Numbers on Obesity

A Lancet Commission definition integrating BMI with anthropometric measures increased obesity prevalence by ~60% in a major US cohort, identifying previously unrecognized high-risk patients while introducing distinct clinical phenotypes.

Conexiant

October 16, 2025

Cardiac Rehab Participation One-Third Lower in Women

Women remain underrepresented in cardiac rehabilitation across all stages of participation.

Conexiant

October 15, 2025

Medical Oddities: The Half-Hour Health Hack

Metabolic tweaks, sensory sweet spots, antiviral spice, and a soothing cup for the heart and more this week.

Conexiant

October 14, 2025

Breast Screening: The Age Question

Screening every two years offers greater life-year gains in breast cancer care.

Conexiant

October 10, 2025

Lobular Breast Cancer Rates Rising Nationwide, Study Shows

Lobular breast cancers present larger, HR-positive tumors and lower long-term survival rates.

Conexiant

October 08, 2025

New Data Tie GLP-1 Therapies to GERD

"These potential risks should be weighed against the established clinical benefits of this drug class."

Conexiant

October 07, 2025

Who's Leaving Medicine and Why?

Nationwide study reveals clinical practice departure rates jumped 40% from 2013 to 2019, with patient complexity driving workforce losses.

Conexiant